Evidence map›Paper›PMID 41181642›Full record

ArticlePatient preference and adherence2025

Patient Expectations in Allergic Rhinitis Treatment: A Mixed-Methods Study.

Ana Noreña-Peña, Fernando Mugarza Borque, Jorge Mestre-Ferrandiz, Jesús Diaz Olmo, Vicente F Gil-Guillén, Ramón Rodríguez Pacheco, María Mercedes Rizo-Baeza, Ernesto Cortés-Castell

Abstract read
In one paragraph

Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Clinical Efficacy of TM02Current issues in molecular biology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ana Noreña-PeñaDepartment of Nursing, University of Alicante, Alicante, Spain.
Fernando Mugarza BorqueChair of the Patient, University of Alicante, Alicante, Spain.
Jorge Mestre-FerrandizProPatiens Institute, Madrid, Spain.
Jesús Diaz OlmoChair of the Patient, University of Alicante, Alicante, Spain.
Vicente F Gil-GuillénChair of the Patient, University of Alicante, Alicante, Spain.
Ramón Rodríguez PachecoAllergology Department, General University Hospital of Elda, Alicante, Spain.ORCID 0009-0009-8574-6402
María Mercedes Rizo-BaezaDepartment of Nursing, University of Alicante, Alicante, Spain.
Ernesto Cortés-CastellChair of the Patient, University of Alicante, Alicante, Spain.ORCID 0000-0002-8079-1695

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Understanding patients' expectations and needs regarding allergic rhinitis (AR) treatment is key to improving adherence and outcomes. A patient-centered approach that considers subjective treatment perceptions can provide valuable insights for improving disease management. Objective: To explore the subjective experience of patients with moderate to severe AR regarding their treatment, exploring expectations, needs, and adherence. Methods: An observational, descriptive, cross-sectional study with a mixed-methods design was conducted during the first four months of 2024 through the Spanish Federation of Associations of Allergy and Respiratory Disease Patients (FENAER). The study included a quantitative survey (56 questions) completed by 75 patients with moderate to severe AR and a qualitative focus group with 7 patients. The focus group explored key concerns, justifications, and proposed solutions. Results: The mean age of participants was 42.3 (SD21.7) years, with 65.3% of participants being female, 84% had moderate and 16% severe AR. Seventy-two percent reported symptom fluctuations since diagnosis, and 69% indicated an impact on daily activities, leisure, or sports. Side effects were reported by 18.6% of patients, all of whom informed their healthcare provider. While 73.3% were satisfied with their treatment, 33.3% had considered requesting a change, primarily due to perceived efficacy. More than half (54.7%) reported high adherence, yet 26.7% found treatment costs high. Regarding disease information, 58.6% found it useful, but 82.7% desired more education on AR and treatment options. The qualitative analysis revealed 15 key themes, including the need for individualized therapies, simpler administration methods, better communication with healthcare providers, emotional support, and the role of patient associations in facilitating education and adherence. Conclusion: This study highlights the need for a patient-centered approach in AR management. Beyond efficacy, factors such as ease of administration, side effects, and communication influence satisfaction and adherence. Involving patients in decisions may improve outcomes and quality of life.

Indexed as

allergic rhinitisfocus groupsmedication adherencepatient-centered carepatient satisfaction

Identifiers

PMID41181642
PMCPMC12574445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.